Artificial Intelligence in Chemistry: Accelerating Drug Development
Introduction
Artificial intelligence (AI) is stirring up significant changes in the field of chemistry, particularly in the development of new drugs. ReactWise, a YC-backed startup, is leading the charge by using AI to speed up the chemical manufacturing process.
Chemical Process Optimization
ReactWise’s “AI copilot for chemical process optimization” accelerates the process of figuring out the best method for making a drug by 30x the standard trial-and-error-based process. According to co-founder and CEO Alexander Pomberger, “making drugs is really like cooking. You need to find the best recipe to make a drug with a high purity and a high yield.”
Process Development
The industry has relied on trial-and-error or staff expertise for process development, but automation offers a way to shrink the number of iteration cycles required to land on a solid recipe for manufacturing a drug. The startup’s machine learning AI models can still deliver major savings by reducing the number of iterations needed to get past this part of the drug development chain.
Cutting through the Tedium
Pomberger and his team have been working on consolidating five years of academic research into a simple software that can predict the ideal experiment almost immediately, without the need for multiple iterations where data on each experiment is fed back in to further hone predictions.
Pre-seed Funding
ReactWise received $3.4 million in pre-seed funding, which includes $500,000 from YC and an Innovate U.K. grant of close to £1.2 million (around $1.6 million). The rest of the funding (around $1.5 million) is coming from unnamed venture capitalists and angel investors who are committed to advancing AI-driven, sustainable pharmaceutical manufacturing.
Conclusion
ReactWise’s AI-driven approach to chemical process optimization can significantly accelerate the development of new drugs, reducing the time it takes to get new pharmaceuticals to patients. With its pre-seed funding, the startup is poised to revolutionize the industry and make a meaningful impact on public health.
FAQs
Q: What is ReactWise’s AI copilot for chemical process optimization?
A: ReactWise’s AI copilot accelerates the process of figuring out the best method for making a drug by 30x the standard trial-and-error-based process.
Q: How does the startup’s machine learning AI models work?
A: The startup’s machine learning AI models can still deliver major savings by reducing the number of iterations needed to get past this part of the drug development chain.
Q: What is the inspiration behind ReactWise’s product?
A: The inspiration for ReactWise’s product came from Pomberger’s experience working in Big Pharma, where he saw how tedious and trial-and-error driven the whole industry is.
Q: What is the future of ReactWise’s technology?
A: ReactWise is working towards delivering “one shot prediction” in the near future, where the AI will be able to predict the ideal experiment almost immediately, without the need for multiple iterations.
